Fact CheckerSign in

NCT07887802Completed

Multimodal Rehabilitation and Balance Assessment in Parkinson's Disease

Instrumented Balance Assessment in Parkinson's Disease: Associations With Clinical Balance and Changes Following Multimodal Rehabilitation

Source: ClinicalTrials.gov · Last updated 21 Oct 2026

Brief summary (registry, in English)

This study aimed to investigate the relationship between instrumented balance measurements and clinical balance assessments in individuals with Parkinson's disease and to evaluate changes in balance and functional mobility following a 12-week multimodal rehabilitation program. Eighteen individuals with Parkinson's disease participated in this prospective, single-group study. All participants received a rehabilitation program that included balance exercises, aerobic exercise, and balance training using the Korebalance system. The program was conducted twice weekly for 12 weeks. Balance was assessed using the Korebalance system and the Berg Balance Scale (BBS). Functional mobility was evaluated using the Timed Up and Go (TUG) test. Assessments were performed before and after the rehabilitation program. The study examined whether instrumented balance measurements were associated with clinical balance performance and whether balance and functional mobility changed following rehabilitation.

Status (registry)
Completed
Study type
Interventional
Enrollment
18 (actual)
First submitted
15 Oct 2026
Start date
5 Feb 2024
Primary completion date
17 Aug 2026
Lead sponsor
Bilinç Doğruöz Karatekin
NCT number
NCT07887802

What you commit to

  • Study type: Interventional
  • Participants enrolled: 18
  • From 5 Feb 2024 to the primary completion date, 17 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Advanced Parkinson's disease (Hoehn and Yahr stages 4-5).
  • Significant cognitive impairment that could interfere with participation or assessment.
  • Other neurological disorders affecting balance or mobility.
  • History of surgery within the preceding six months.
  • Severe or uncontrolled systemic diseases that could interfere with safe participation in the rehabilitation program.

Other

  • Refusal or inability to provide informed consent.

Who the study is looking for

  • Adults aged 18 years or older.
  • Diagnosis of Parkinson's disease.
  • Hoehn and Yahr stages 1-3.
  • Sufficient cognitive function to understand and follow instructions during assessments and rehabilitation.
  • Ability to participate in the rehabilitation program.
  • Provision of written informed consent.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Goztepe Prof. Dr. Suleyman Yalcin City Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.